Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSEPT 2: Eptacog Beta in Pediatric Hemophilia with Inhibitors
NCT02448680Phase 3Completed
- Sponsor
- LFB Group
- Start
- Dec 2015
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by LFB Group. Started Dec 2015; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT02448680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448680.